Back

TAHO Pharmaceuticals to join Taiwan main board at NT$105.6 on Oct. 20

Verifying
  • TAHO Pharmaceuticals is set to transition to Taiwan’s main board listing.
  • NT$105.6 is the company’s tentative underwriting price.
  • October 20 is the scheduled date for the Taiwan Stock Exchange transition.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.